Key facts
- Bloom Surgical’s last known valuation is $6.5M (May 2025).
- It has raised $1.0M; the latest was Seed Round ($1.0M) in May 2025.
- Notable investors include US National Science Foundation, Impact Assets, VentureWell, ASU Innovation Open, Brigham Young University — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Bloom Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Bloom Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bloom Surgical
Developer of surgical equipment designed to resolve intraoperative visual disruptions with an in-abdomen, rapid-response scope lens cleaning tool. The company's device reduces time spent with compromised vision and scope removals to assist in vivo cleaning, enabling surgeons to improve patient safety and procedure efficiency.
- Sector
- Healthcare
- HQ
- Highland, UT, United States
- Founded
- 2021
- Employees
- 10
- Website
- bloomsurgical.com/
- Ownership
- Privately Held (backing)
Bloom Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bloom Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bloom Surgical in its N-PORT filings yet. We sweep new filings monthly.